SANGRIX INC. Class A Ordinary Shares
SGRX
5 hedge funds and large institutions have $103K invested in SANGRIX INC. Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
40% less capital invested
Capital invested by funds: $173K → $103K (-$70K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$50K |
| 2 |
VF
Virtu Financial
New York
|
+$28.6K |
| 3 |
Renaissance Technologies
New York
|
+$7.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$15K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$7.15K |
SGRX Hedge Fund Activity: Q2 2022 in Review
5 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in SANGRIX INC. Class A Ordinary Shares (SGRX) for Q2 2022, worth a combined $103K — down 40% from $173K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SGRX positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $50K. The largest seller was Citigroup, exiting entirely with an estimated $15K sold.
- 5 institutional investors held SANGRIX INC. Class A Ordinary Shares (SGRX) as of Q2 2022, up from 4 in Q1 2022.
- Funds reported $103K of SANGRIX INC. Class A Ordinary Shares stock for Q2 2022, down 40% quarter-over-quarter.
- 2 funds opened new SANGRIX INC. Class A Ordinary Shares positions in Q2 2022 and 1 closed out, a net change of +1 holder.
- The largest SANGRIX INC. Class A Ordinary Shares buyer in Q2 2022 was Citadel Advisors, an estimated $50K added.
- The largest SANGRIX INC. Class A Ordinary Shares seller in Q2 2022 was Citigroup, an estimated $15K sold.
Based on aggregated 13F filings for Q2 2022.